- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Oncolytics Biotech Inc
+ Add to WatchlistONC:CN
2.7100 CAD 0.0900 3.21%As of 15:59:59 ET on 05/24/2013.
Company Profile for Oncolytics Biotech Inc (ONC)
Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.
Contact Information
Oncolytics Biotech Inc
Suite 210
1167 Kensington Crescent NW
Calgary, AB T2N 1X7
Canada
Key Executives for Oncolytics Biotech Inc (ONC)
| Bradley G Thompson "Brad"Chairman/President/CEO | Kirk LookChief Financial Officer |
| Matthew C Coffey "Matt"Chief Operating Officer | Alan J TuchmanSenior VP:Clinical/Chief Medical Ofcr |
| George M GillSenior VP:Regulatory Affairs | Mary Ann DillahuntyVP:Intellectual Property |
| Jeremy GrushcowGeneral Counsel |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page